14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CGBD vs PSEC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Carlyle Secured Lending, Inc. (CGBD) captures the overall head-to-head institutional edge over Prospect Capital Corporation (PSEC) on higher Unified Composite conviction (51.3/100 HOLD vs. 46.7/100 HOLD) after splitting the core matrix 6–4 (led by Profitability & Quality, Balance Sheet & Cash Flow), while PSEC wins 3–2 across the 6-pillar growth and valuation breakdown. CGBD trades at $10.90 (7.4x Forward P/E, 74.0% operating margin) versus PSEC at $1.33 (4.2x Forward P/E, 71.1% operating margin).
Growth vs. Quality Trade-Off: CGBD earns the overall head-to-head edge with a stronger Unified Composite Score (51.3/100 HOLD vs. PSEC 46.7/100 HOLD) and 0.44β · 24% Vol risk profile, whereas PSEC leads top-line expansion (-3.7% YoY revenue growth, 1.55x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: CGBD is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8); meanwhile PSEC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CGBD vs PSEC. Trailing 12-month operating profitability (CGBD 74.0% vs PSEC 71.1%) and valuation multiples (CGBD 7.4x vs PSEC 4.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Asset Management value chain with $750.2M market capitalization and 74.0% operating margin.
OpEx & R&D Reinvestment26.0% of Rev ($67M)
90D Engineering Disclosures0 Published
PSEC Moat ProfileHigh-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $782.6M market capitalization and 71.1% operating margin.
OpEx & R&D Reinvestment28.9% of Rev ($183M)
90D Engineering Disclosures0 Published
Investor FAQ CGBD vs PSEC Key Questions & Quantitative Answers
As of Nov 16, 2026, Carlyle Secured Lending, Inc. (CGBD) captures the overall head-to-head institutional edge over Prospect Capital Corporation (PSEC) on higher Unified Composite conviction (51.3/100 HOLD vs. 46.7/100 HOLD) after splitting the core matrix 6–4 (led by Profitability & Quality, Balance Sheet & Cash Flow), while PSEC wins 3–2 across the 6-pillar growth and valuation breakdown. CGBD trades at $10.90 (7.4x Forward P/E, 74.0% operating margin) versus PSEC at $1.33 (4.2x Forward P/E, 71.1% operating margin). Growth vs. Quality Trade-Off: CGBD earns the overall head-to-head edge with a stronger Unified Composite Score (51.3/100 HOLD vs. PSEC 46.7/100 HOLD) and 0.44β · 24% Vol risk profile, whereas PSEC leads top-line expansion (-3.7% YoY revenue growth, 1.55x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CGBD is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8); meanwhile PSEC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
PSEC leads the Growth & Scale pillar: CGBD posts -7.7% YoY revenue growth and -40.5% YoY earnings growth on $260M TTM revenue (100.0% gross margin, 74.0% operating margin), compared with PSEC at -3.7% YoY revenue growth and -78.2% YoY earnings growth on $634M TTM revenue (100.0% gross margin, 71.1% operating margin). On trailing 12-month operating scale, CGBD generates $260M in USD-normalized revenue versus $634M for PSEC. In operating R&D and SG&A reinvestment, CGBD deploys 26.0% of Rev ($67M) (0 90-day corporate R&D disclosures) versus 28.9% of Rev ($183M) (0 disclosures) for PSEC.
PSEC screens cheaper on headline valuation multiples. CGBD trades at 7.4x Forward P/E, 21.6x Trailing P/E, 3.54x PEG, and 2.9x EV/Revenue (unreported cash flow margin), whereas PSEC trades at 4.2x Forward P/E, 9.4x Trailing P/E, 1.55x PEG, and 1.2x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CGBD (3.2% ROE) versus PSEC (1.2% ROE) capital efficiency.
In options market volatility and institutional positioning, CGBD carries 24.9% implied volatility (65th %ile, Elevated (60th–80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 24% Vol realized risk). By comparison, PSEC carries 26.1% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.86β · 63% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.